120 related articles for article (PubMed ID: 38482616)
1. Nano-delivery of Silibinin Potentiate the Induction of Immunogenic Cell Death (ICD) in Melanoma Cells.
Amiri M; Jafari S; Lavasanifar A; Molavi O; Montazersaheb S
Curr Pharm Biotechnol; 2024 Mar; ():. PubMed ID: 38482616
[TBL] [Abstract][Full Text] [Related]
2. Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy.
Jafari S; Heydarian S; Lai R; Mehdizadeh Aghdam E; Molavi O
Bioimpacts; 2023; 13(1):51-61. PubMed ID: 36816998
[No Abstract] [Full Text] [Related]
3. Chrysin and chrysin-loaded nanocarriers induced immunogenic cell death on B16 melanoma cells.
Oliyapour Y; Dabiri S; Molavi O; Hejazi MS; Davaran S; Jafari S; Montazersaheb S
Med Oncol; 2023 Aug; 40(10):278. PubMed ID: 37624439
[TBL] [Abstract][Full Text] [Related]
4. Novel calreticulin-nanoparticle in combination with focused ultrasound induces immunogenic cell death in melanoma to enhance antitumor immunity.
Sethuraman SN; Singh MP; Patil G; Li S; Fiering S; Hoopes PJ; Guha C; Malayer J; Ranjan A
Theranostics; 2020; 10(8):3397-3412. PubMed ID: 32206098
[No Abstract] [Full Text] [Related]
5. Chemoimmunotherapy with doxorubicin and caffeine combination enhanced ICD induction and T-cell infiltration in B16F10 melanoma tumors.
Yerragopu AK; Vellapandian C
J Biochem Mol Toxicol; 2023 May; 37(5):e23327. PubMed ID: 36807623
[TBL] [Abstract][Full Text] [Related]
6. STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells.
Jafari S; Lavasanifar A; Hejazi MS; Maleki-Dizaji N; Mesgari M; Molavi O
Daru; 2020 Jun; 28(1):159-169. PubMed ID: 31942696
[TBL] [Abstract][Full Text] [Related]
7. Chromomycin A
Florêncio KGD; Edson EA; Fernandes KSDS; Luiz JPM; Pinto FDCL; Pessoa ODL; Cunha FQ; Machado-Neto JA; Wilke DV
Front Immunol; 2022; 13():941757. PubMed ID: 36439184
[TBL] [Abstract][Full Text] [Related]
8. Poly(ethylene glycol)-poly(ε-caprolactone)-based micelles for solubilization and tumor-targeted delivery of silibinin.
Hassankhani Rad A; Asiaee F; Jafari S; Shayanfar A; Lavasanifar A; Molavi O
Bioimpacts; 2020; 10(2):87-95. PubMed ID: 32363152
[No Abstract] [Full Text] [Related]
9. Nano-Pulse Stimulation is a physical modality that can trigger immunogenic tumor cell death.
Nuccitelli R; McDaniel A; Anand S; Cha J; Mallon Z; Berridge JC; Uecker D
J Immunother Cancer; 2017; 5():32. PubMed ID: 28428881
[TBL] [Abstract][Full Text] [Related]
10. Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression.
Kim M; Lee JS; Kim W; Lee JH; Jun BH; Kim KS; Kim DE
J Control Release; 2022 Aug; 348():893-910. PubMed ID: 35760233
[TBL] [Abstract][Full Text] [Related]
11. Functionalized Caprolactone-Polyethylene Glycol Based Thermo-Responsive Hydrogels of Silibinin for the Treatment of Malignant Melanoma.
Makhmalzadeh BS; Molavi O; Vakili MR; Zhang HF; Solimani A; Abyaneh HS; Loebenberg R; Lai R; Lavasanifar A
J Pharm Pharm Sci; 2018; 21(1):143-159. PubMed ID: 29789104
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic Newcastle disease virus induces autophagy-dependent immunogenic cell death in lung cancer cells.
Ye T; Jiang K; Wei L; Barr MP; Xu Q; Zhang G; Ding C; Meng S; Piao H
Am J Cancer Res; 2018; 8(8):1514-1527. PubMed ID: 30210920
[TBL] [Abstract][Full Text] [Related]
13. Bullatacin triggers immunogenic cell death of colon cancer cells by activating endoplasmic reticulum chaperones.
Fan F; Shen P; Ma Y; Ma W; Wu H; Liu H; An Q
J Inflamm (Lond); 2021 Jun; 18(1):23. PubMed ID: 34112202
[TBL] [Abstract][Full Text] [Related]
14. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R
Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
[TBL] [Abstract][Full Text] [Related]
15. Schweinfurthin induces ICD without ER stress and caspase activation.
Zhang R; Neighbors JD; Schell TD; Hohl RJ
Oncoimmunology; 2022; 11(1):2104551. PubMed ID: 35936984
[TBL] [Abstract][Full Text] [Related]
16. STAT3 Contributes To Oncolytic Newcastle Disease Virus-Induced Immunogenic Cell Death in Melanoma Cells.
Shao X; Wang X; Guo X; Jiang K; Ye T; Chen J; Fang J; Gu L; Wang S; Zhang G; Meng S; Xu Q
Front Oncol; 2019; 9():436. PubMed ID: 31192135
[No Abstract] [Full Text] [Related]
17. The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth.
Rodríguez-Salazar MDC; Franco-Molina MA; Mendoza-Gamboa E; Martínez-Torres AC; Zapata-Benavides P; López-González JS; Coronado-Cerda EE; Alcocer-González JM; Tamez-Guerra RS; Rodríguez-Padilla C
Oncol Lett; 2017 Jul; 14(1):844-852. PubMed ID: 28693241
[TBL] [Abstract][Full Text] [Related]
18. Process of immunogenic cell death caused by disulfiram as the anti-colorectal cancer candidate.
You SY; Rui W; Chen ST; Chen HC; Liu XW; Huang J; Chen HY
Biochem Biophys Res Commun; 2019 Jun; 513(4):891-897. PubMed ID: 31003768
[TBL] [Abstract][Full Text] [Related]
19. Targeting β-catenin using XAV939 nanoparticle promotes immunogenic cell death and suppresses conjunctival melanoma progression.
Antony F; Kang X; Pundkar C; Wang C; Mishra A; Chen P; Babu RJ; Suryawanshi A
Int J Pharm; 2023 Jun; 640():123043. PubMed ID: 37172631
[TBL] [Abstract][Full Text] [Related]
20. Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal.
Garg AD; Elsen S; Krysko DV; Vandenabeele P; de Witte P; Agostinis P
Oncotarget; 2015 Sep; 6(29):26841-60. PubMed ID: 26314964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
